-1 C
Munich
Friday, January 27, 2023

Jabil (NYSE: JBL) and SaltMED Confirm Manufacturing Agreement

Jabil Inc. (NYSE: JBL) and SaltMED have confirmed the manufacturing agreement to become the company’s manufacturer and supplier of SaltMED’s current and future products. Jabil has decided to manufacture The SaltFacial because it is a market disruptor and has an enormous opportunity to scale.

The SaltFacial gadget is essential for medical aesthetic offices and providers all over the world looking for a patented, real medical facial technology developed in the United States. Current SaltFacial providers are witnessing over 70% of their customers book their next appointment for a SaltFacial treatment within 4-6 weeks of their initial treatment. It results in significant practice development in other areas such as skincare and injectable.

Furthermore, the SaltFacial was chosen by Jabil to be manufactured because it is a market disruptor in the medical aesthetics business with a lot of room for growth. The SaltFacial fits Jabil’s high criteria of offering the greatest technology while growing into the medical aesthetic market, as the industry’s largest provider of design, engineering, and manufacturing solutions to the medical profession, Jabil’s Director of Business Development, Jim Warren, stated.

Additionally, we are grateful to Jabil for entrusting us with delivering world-class technology in the medical aesthetics business,” stated Allan Danto, President, and CEO of SaltMED. “Due to the significant level of demand from both providers and consumers seeking The SaltFacial’s unique and original technology, we have set quick action plans and a plan to expand The SaltFacial distribution in the early second half of 2022.”

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.